AIA Group Ltd

SEC CIK: 0001522877
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by AIA Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overview All 13F holders of RARE Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2022

Holdings of RARE by AIA Group Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−4,000−100.0%	Sold out	Holders
Q1 2022	4,000	$290.0K	<0.1%	+4,000	New	Holders